Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

TUESDAY, Nov. 12, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Emrosi (minocycline ... The ...

Novavax yesterday announced that the US Food and Drug Administration (FDA) has released a clinical hold on its new drug ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

The FDA lifted a clinical hold that had been placed on Novavax's investigational new drug application after the company addressed concerns related to a serious adverse event reported in a phase 2 ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

An updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid ...